Go Back

Imagine revenue management without the friction

FinThrive creates integrated technology that adapts with healthcare professionals – freeing them from complexity and inefficiency so they can focus on doing their best work. Our end-to-end revenue management platform provides financial teams and stakeholders with greater reliability and control to deliver better outcomes for everyone. With our vision, technology, experience and scale, we’re advancing the healthcare economy.

FinThrive

Healthcare

Stormy Weather: Navigating Profitability in the NFP Hospital Space with Kevin Holloran

February 15, 2023

Hospitals had a rough 2022 as they faced higher labor and supply costs, volatile patient volumes, and fragile payer relations. More than half of hospitals in 2022 are expected to result in negative margins, according to Kaufman Hall. Kevin Holloran, Senior Director at Fitch Ratings, said 2022 was “one of the worst years ever in healthcare,” and he projected hospitals would face a bumpy 2023.

On this episode of Healthcare Rethink, Jonathan Wiik, VP of Health Insights at FinThrive and Kevin Holloran dig deeper into financial performance for health systems and hospitals.

Topics covered:

  • Headwinds affecting the not-for-profit hospital sector and what is driving those headwinds
  • Advice for CFOs and recommendation to insulate operations and profitability
  • Thoughts on M&A activity
  • How the future of payer/provider collaboration may look
  • Issues affecting profitability from labor to patient volumes and possible impact from recent legislation

Recent Episodes

CensisAI²
View episode

Inside the SPD Revolution: Robby Miller on Embracing CensisAI²

In this impactful episode of the ConCensis podcast, host Yasmeen Hassan sits down with Robby Miller, Sterile Processing Manager at St. Joseph’s Hospital Medical Center, to explore how artificial intelligence is revolutionizing the field of sterile processing. With nearly 30 years of experience in healthcare, Miller shares his journey from EMT to SPD leader, offering…

resistance
View episode

Inside Oncology Drug Development: Overcoming Resistance with Science

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

organoids
View episode

Growing the Future of Cancer Research: Inside the Promise of Organoids

In an era where precision and predictability define the future of oncology, organoid technology is emerging as a transformative tool in drug discovery. These miniature, lab-grown 3D tissues mirror real human biology more closely than traditional 2D models or even animal systems, offering researchers the potential to predict patient-specific drug responses. As organoids become more…

Launch Your Branded Show Today

Engage your audience with original, industry-specific content.

Book a Demo Talk to an Expert